What changed in this filing

/stocks — the workspaceLOADING

Item 8. Financial Statements and Supplementary Data

2014-06-25 compared with 2013-03-22 · 599 added, 255 removed, 280 unchanged (75% of the section changed)

5 unchanged sentences

Financial Statements:

Report of Independent Registered Public Accounting Firm

Report of Independent Registered Public Accounting Firms

Balance Sheets as of December 31, 2013 and 2012

Statements of Operations and Accumulated Other Comprehensive Loss for the Years Ended December 31, 2012 and 2011 and Development Stage from October 1, 2011 to December 31, 2012

Statements of Operations and Comprehensive Loss for the Years Ended December 31, 2013 and 2012 and Development Stage from October 1, 2011 to December 31, 2013

Statements of Changes in Stockholders’ Equity (Deficit) for the Years Ended December 31, 2013 and 2012 and Development Stage from October 1, 2011 to December 31, 2013

2 unchanged sentences

Report of Independent Registered Public Accounting Firm

To the Board of Directors of

Bio-Solutions Corp.

We have audited the accompanying balance sheet of Bio-Solutions Corp.

(the "Company") as of December 31, 2013, and the related statements of operations and other comprehensive loss, changes in stockholders' equity (deficit) and cash flows for the year ended December 31, 2013.

These financial statements are the responsibility of the Company’s management.

Our responsibility is to express an opinion on these financial statements based on our audit.

The financial statements of the Company as of December 31, 2012 and for the year then ended and for the period from October 1, 2011 through December 31, 2012 (Development Stage) were audited by other auditors, whose report dated March 22, 2013, express an unqualified opinion on those financial statements and also included an explanatory paragraph that raise substantial doubt about the Company’s ability to continue as a going concern.

We conducted our audit in accordance with standards of the Public Company Accounting Oversight Board (United States).

Those standards require that we plan and perform the audit to obtain reasonable assurance about whether the financial statements are free of material misstatement.

We were not engaged to perform an audit of the Company’s internal control over financial reporting.

Our audit included consideration of internal control over financial reporting as a basis for designing audit procedures that are appropriate in the circumstances, but not for the purpose of expressing an opinion on the effectiveness of the Company’s internal control over financial reporting.

Accordingly, we express no such opinion.

An audit includes examining, on a test basis, evidence supporting the amounts and disclosures in the financial statements.

An audit also includes assessing the accounting principles used and significant estimates made by management, as well as evaluating the overall financial statement presentation.

We believe that our audit provides a reasonable basis for our opinion.

In our opinion, the financial statements referred to above present fairly, in all material respects, the financial position of the Company as of December 31, 2013, and its results of operations, and cash flows for the year ended December 31, 2013 in conformity with U.S.

generally accepted accounting principles.

The accompanying financial statements have been prepared assuming that the Company will continue as a going concern.

As discussed in Note 1 to the financial statements, the Company is in process of executing its business plan and expansion.

The Company has not generated significant revenue to this point.

The lack of profitable operations and the need to continue to raise funds raise significant doubt about the Company’s ability to continue as a going concern.

Management’s plans in this regard are described in Note 1.

The financial statements do not include any adjustments that might result from the outcome of this uncertainty.

/s/ Anton & Chia, LLP

Newport Beach, California

June 20, 2014

Report of Independent Registered Public Accounting Firm

To the Directors of

1 unchanged sentence

We have audited the accompanying balance sheets of Bio-Solutions Corp.

(the "Company") as of December 31, 2012 and 2011, and the related statements of operations and accumulated other comprehensive loss, changes in stockholders' equity (deficit) and cash flows for the years ended December 31, 2012 and 2011.

(the "Company") as of December 31, 2012, and the related statements of operations and comprehensive loss, changes in stockholders' equity (deficit) and cash flows for the year ended December 31, 2012 and for the statements of operations and comprehensive loss, changes in stockholders’ equity (deficit) and cash flows for the period October 1, 2011 through December 31, 2012 (Development Stage).

These financial statements are the responsibility of the Company’s management.

9 unchanged sentences

In our opinion, the financial statements referred to above present fairly, in all material respects, the financial position of Bio-Solutions Corp.

as of December 31, 2012 and 2011, and the results of its statements of operations and accumulated other comprehensive loss, changes in stockholders’ equity (deficit), and cash flows for the year ended December 31, 2012 and 2011 in conformity with U.S.

as of December 31, 2012, and the results of its statements of operations and comprehensive loss, changes in stockholders’ equity (deficit), and cash flows for the year ended December 31, 2012 and for the statements of operations and comprehensive loss, changes in stockholders’ equity (deficit) and cash flows for the period October 1, 2011 through December 31, 2012 (Development Stage) in conformity with U.S.

generally accepted accounting principles.

2 unchanged sentences

The Company has not generated significant revenue to this point, however, has been successful in raising funds in their private placement.

The lack of profitable operations and the need to continue to raise funds raise significant doubt about the Company’s ability to continue as a going concern.

The lack of profitable operations and the need to continue to raise funds raise substantial doubt about the Company’s ability to continue as a going concern.

Management’s plans in this regard are described in Note 1.

3 unchanged sentences

(A DEVELOPMENT STAGE COMPANY)

BALANCE SHEETS

BALANCE SHEETS AS OF

DECEMBER 31, 2013 AND 2012

CURRENT ASSETS

Prepaid expenses

Total current assets

Intellectual Property

LIABILITIES AND STOCKHOLDERS EQUITY (DEFICIENECY)

LIABILITIES AND STOCKHOLDERS' EQUITY (DEFICIT)

CURRENT LIABILITIES

Accounts payable and accrued expenses

Liability for stock to be issued

Short - term loans

1 unchanged sentence

Short - term loans - convertible

Due to officer

Total current liabilities

TOTAL LIABILITIES

STOCKHOLDERS' EQUITY (DEFICIENCY)

STOCKHOLDERS' EQUITY (DEFICIT)

Common stock, $0.001 par value, 200,000,000 shares authorized,

2 unchanged sentences

Additional paid in capital

Stock to be issued

Deferred compensation

2 unchanged sentences

Accumulated other comprehensive loss

Total stockholders' equity (deficiency)

TOTAL LIABILITIES AND STOCKHOLDERS' EQUITY (DEFICIENCY)

Total stockholders' equity (deficit)

TOTAL LIABILITIES AND STOCKHOLDERS' EQUITY (DEFICIT)

(1) The common stock shares authorized, issued and outstanding have been adjusted to reflect a 10 to 1 reverse split, which was effective in February 2014.

The accompanying notes are an integral part of these financial statements.

1 unchanged sentence

(A DEVELOPMENT STAGE COMPANY)

STATEMENTS OF OPERATIONS AND ACCUMULATED OTHER COMPREHENSIVE LOSS

FOR THE YEARS ENDED DECEMBER 31, 2012 AND 2011 AND DEVELOPMENT STAGE OCTOBER 1, 2011 THROUGH DECEMBER 31, 2012

DEVELOPMENT STAGE

OCTOBER 1, 2011 to

STATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSS

FOR THE YEARS ENDED DECEMBER 31, 2013 AND 2012 AND FROM OCTOBER 1, 2011 THROUGH DECEMBER 31, 2013

DECEMBER 31, 2013

DECEMBER 31, 2012

DECEMBER 31, 2013

COST OF REVENUES

Beginning inventory

Purchases/Write-off of obsolete inventory

Ending inventory

Total Cost of Revenues

GROSS PROFIT (LOSS)

OPERATING EXPENSES

Professional fees

Professional fees/stock based compensation

Amortization expense and impairment

1 unchanged sentence

Total operating expenses

NET LOSS BEFORE OTHER EXPENSE

OTHER EXPENSE

Interest expense

Total other expense

WEIGHTED AVERAGE NUMBER OF SHARES OUTSTANDING

NET LOSS PER SHARE

STATEMENT OF ACCUMULATED OTHER COMPREHENSIVE LOSS

LOSS FROM OPERATIONS

OTHER INCOME (EXPENSE)

Interest income (expense)

Loss on conversion of debt

Total other expense, net

LOSS BEFORE IMCOME TAXES

PROVISION FOR (BENEFIT FROM) INCOME TAXES

WEIGHTED AVERAGE NUMBER OF SHARES OUTSTANDING - BASIC AND DILUTED (2)

NET LOSS PER SHARE - BASIC AND DILUTED

STATEMENT OF COMPREHENSIVE LOSS

Currency translation gains (losses)

TOTAL ACCUMULATED OTHER COMPREHENSIVE LOSS

TOTAL COMPREHENSIVE LOSS

(2) The common stock shares authorized, issued and outstanding have been adjusted to reflect a 10 to 1 reverse split, which was effective in February 2014.

The accompanying notes are an integral part of these financial statements.

1 unchanged sentence

(A DEVELOPMENT STAGE COMPANY)

STATEMENT OF CHANGES IN STOCKHOLDERS' EQUITY

FOR THE YEARS ENDED DECEMBER 31, 2012 AND 2011

STATEMENT OF CHANGES IN STOCKHOLDERS' EQUITY (DEFICIT)

FOR THE YEARS ENDED DECEMBER 31, 2013 AND 2012 AND FROM OCTOBER 1, 2011 THROUGH DECEMBER 31, 2013

Deficit During

Comprehensive

Balance - December 31, 2010

Common shares issued for services

Common shares issued for settlement of accounts payable

Common shares issued for settlement of notes payable

Proceeds from issuance of common stock

Net loss for the year

Balance - September 30, 2011

Development Stage Period from October 1, 2011 to December 31, 2011

Balance - October 1, 2011 (3)

Common shares issued for services

1 unchanged sentence

Common shares issued for Type 2 Acquisition

Conversion of accounts payable to equity (Note 7)

Conversion of accounts payable to equity

Net loss for the year

Balance - December 31, 2011 (3)

Development Stage Period from October 1, 2011 to December 31, 2012

Common shares issued for liability for stock to be issued

4 unchanged sentences

Conversion of accounts payable and notes payable to equity (Note 8)

Beneficial Conversion Feature of Notes Payable

Discounts on shares issued for notes payable

Amortization of deferred compensation

1 unchanged sentence

Balance - December 31, 2012 (3)

Common shares issued for services

Common shares issued for settlement of notes payable

Common shares issued for settlement of accounts payable

Discounts on shares issued for notes payable

Stock to be issued

Amortization of deferred compensation

Net loss for the year

Balance - December 31, 2013 (3)

(3) The common stock shares authorized, issued and outstanding have been adjusted to reflect a 10 to 1 reverse split, which was effective in February 2014.

The accompanying notes are an integral part of these financial statements.

1 unchanged sentence

(A DEVELOPMENT STAGE COMPANY)

STATEMENTS OF CASH FLOW

FOR THE YEARS ENDED DECEMBER 31, 2012 AND 2011 AND DEVELOPMENT STAGE OCTOBER 1, 2011 THROUGH DECEMBER 31, 2012

DEVELOPMENT STAGE

STATEMENTS OF CASH FLOWS

FOR THE YEARS ENDED DECEMBER 31, 2013 AND 2012 AND FROM OCTOBER 1, 2011 THROUGH DECEMBER 31, 2013

OCTOBER 1, 2011 THROUGH

2 unchanged sentences

DECEMBER 31, 2013

CASH FLOWS FROM OPERATING ACTIVITIES:

Adjustments to reconcile net loss to net cash used in operating activities:

OPERATING ACTIVITIES:

Adjustments to reconcile net loss

to net cash used in operating activities:

Impairment expense

1 unchanged sentence

Beneficial Conversion Feature of Notes Payable

Change in assets and liabilities

Increase (decrease) in accounts payable and accrued expenses

Loss on conversion of debt

Change in operating assets and liabilities

Increase in inventory

Increase in accounts payable and accrued expenses

Total adjustments

Net cash used in operating activities

CASH FLOWS FROM FINANCING ACTIVITIES:

Issuance of stock for cash

Proceeds from short-term loans, net of repayments

Proceeds from short-term loans - related party, net of repayments

Proceeds from convertible notes payable, net of repayments

FINANCING ACTIVITIES:

Proceeds from notes and loans payable

Principal payments on notes and loans payable

Net cash provided by financing activities

Effect of foreign currency

NET INCREASE (DECREASE) IN CASH AND CASH EQUIVALENTS

CASH AND CASH EQUIVALENTS - BEGINNING OF PERIOD

CASH AND CASH EQUIVALENTS - END OF PERIOD

NONCASH OPERATING AND INVESTING ACTIVITIES:

Effect of exchange rates on cash

NET INCREASE (DECREASE) IN CASH

CASH - BEGINNING OF PERIOD

CASH - END OF PERIOD

NON CASH OPERATING AND INVESTING ACTIVITIES:

Conversion of notes payable and accrued interest to common stock

Conversion of liability to common stock

Acquisition of intellectual property of Type2 Defense for common shares

Conversion of accounts payable and notes payable to equity (Note 9)

17 unchanged sentences

All inventories from the former products were written off as of October 1, 2011.

The Type 2 Defense product is currently under development with the initial shipment expected at the end of March 2013.

The Company has elected to enter the development stage on October 1, 2011 and expects to emerge from the development stage at the end of June 2013.

During October 2012, the board of directors increased the number of common shares authorized from 90,000,000 to 200,000,000 shares.

During February 2013, the Company began the first production run of the Type 2 Defense product.

The product will be completed in May 2013 with sales expected in June 2013.

The Company elected to enter the development stage on October 1, 2011.

The first production run of the Company’s Type 2 Defense product was completed during June 2013.

On July 8, 2013 the Company announced our product was available for on-line sales on Amazon.com.

On July 9, 2013, the Company announced our product was available for on-line sales from our www.Type2Defense.com website.

The first sale was completed in July 2013.

As the Company only had nominal sales in the year ended December 31, 2013, they have remained in the development stage.

The Company will closely monitor their sales and determine at which point in time they will emerge from the development stage.

On January 10, 2014, the Company’s Board of Directors unanimously voted to reverse split the Company’s common stock on the basis of one share of the Company’s common stock for each 10 shares outstanding while maintaining the authorized capital structure of the Company at 200,000,000 shares.

The Board resolution set the date of record for shareholder approval on January 14, 2014.

As of January 29, 2014, the Company obtained the written consent in lieu of a meeting of the shareholders to authorize a reverse split of the Company’s common stock.

Shareholders owning a total of 100,992,469 shares of the Company’s common stock voted in favor of the reverse split.

There were a total of 199,611,900 shares of common stock issued and outstanding as of January 14, 2014 (the date of record).

The number of shares of common stock voting in favor of the reverse split was sufficient for approval.

On February 4, 2014, the Company filed a Certificate of Change with the State of Nevada effecting a 1-for-10 reverse split pursuant to which every ten shares of the Company’s common stock were combined and converted into one share of the Company’s common stock (with all fractional shares resulting there from being rounded up to the next whole share) with the total number of shares of the Company’s authorized common stock remaining at 200,000,000 shares.

The effective date of the above corporate action was February 26, 2014, as approval by the Financial Industry Regulatory Authority.

NOTE 1 - ORGANIZATION AND BASIS OF PRESENTATION (CONTINUED)

Going Concern

These financial statements have been prepared on a going concern basis, which implies the Company will continue to realize its assets and discharge its liabilities in the normal course of business.

The Company has not generated significant revenues since inception and has generated losses totaling $3,442,575 since inception, of which $568,650 are deficits accumulated during the development stage, and needs to raise additional funds to carry out their business plan.

The Company has not generated significant revenues since inception and has generated losses totaling $4,901,721 since inception, of which $2,027,796 are deficits accumulated during the development stage and needs to raise additional funds to carry out its business plan.

The continuation of the Company as a going concern is dependent upon the continued financial support from its shareholders, and the ability of the Company to obtain necessary equity financing to continue operations.

2 unchanged sentences

These factors raise substantial doubt regarding the ability of the Company to continue as a going concern.

The Company estimates that they will need a $650,000 capital infusion will be required to continue operations through the end of 2013.

The Company estimates that they will need a $300,000 capital infusion to continue operations through the end of 2014.

Besides generating revenues from current operations, the Company may need to raise additional capital to expand operations to the point at which the Company can achieve profitability.

2 unchanged sentences

NOTE 2 - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

Prior period correction in the three months ended December 31, 2013

Beginning in the three months ended June 30, 2012 and through the three months ended September 30, 2013, the Company improperly valued the potential beneficial conversion option of the Company’s convertible notes payable.

Based on ASC 470-20-30-16 through 30-18, the beneficial conversion option should have been valued based on the fair market value on the date of issuance and recorded as a debt discount.

The debt discount should have been amortized over the term of the convertible note (longest term was 6 months).

The accumulated impact of the correction was a charge to interest expense of $141,267 and a charge to debt discount on notes payable of $18,508 offset by a credit to additional paid in capital of $159,775.

In-addition, during the quarter ended June 30, 2013, the Company improperly recorded stock-based compensation issued to the Company’s former chief executive officer upon achievement of operational milestones for the Type2Defense product (see Note 10) as intellectual property.

Based on ASC 718-10 and ASC 505-50 this amount should have been classified as stock based compensation on the date earned.

The accumulated impact of the correction on the financial statements was a charge to stock based compensation of $231,600 and a credit to intellectual property of $231,600.

In accordance with the Securities and Exchange Commission's Staff Accounting Bulletin, or SAB, No.

99, Materiality, and SAB No.

108, the Company assessed the materiality of these charges to its financial statements for the quarters ended June 30, 2012 through September 30, 2013 and the year ended December 31, 2013, using both the roll-over method and iron-curtain method as defined in SAB No.

The Company concluded the effect of understating interest expense and share-based compensation was not material to its financial statements for the quarters ended June 30, 2012 through September 30, 2013 and the year ended December 31, 2013 and, as such, those financial statements are not materially misstated.

The Company also concluded that providing for the correction of the understatement in 2013 would not have a material effect on its financial statements for the year ending December 31, 2013.

The out-of-period adjustment at December 31, 2013 for the improperly valued beneficial conversion option of the Company’s convertible notes payable was a charge to interest expense of $141,267 and charge to debt discount on notes payable of $18,508 offset by a credit to additional paid in capital of $159,775 in the accompanying balance sheet and statement of operations.

The out-of-period adjustment at December 31, 2013 for improperly recording stock-based compensation issued to the Company’s former Chief executive officer upon achievement of operational milestones as intellectual property was a charge to stock based compensation of $231,600 and a credit to intellectual property of $231,600 in the accompanying balance sheet and statement of operations.

The impact of the misstatements on the previously issued financial statements and the effect of correcting the misstatements during the three months ended December 31, 2013 are as follows:

NOTE 2 - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (CONTINUED)

Misstatements on previously issued financial statements:

Quarter ended June 30, 2012

Beneficial Conversion Interest Expense

Discount on Notes Payable

Additional paid in capital

Quarter ended September 30, 2012

Beneficial Conversion Interest Expense

Discount on Notes Payable

Additional paid in capital

Quarter ended December 31, 2012

Beneficial Conversion Interest Expense

Discount on Notes Payable

Additional paid in capital

Year ended December 31, 2012

Beneficial Conversion Interest Expense

Discount on Notes Payable

Additional paid in capital

Quarter ended March 31, 2013

Beneficial Conversion Interest Expense

Discount on Notes Payable

Additional paid in capital

Quarter ended June 30, 2013

Stock Based Compensation

Beneficial Conversion Interest Expense

Intellectual property

Discount on Notes Payable

Additional paid in capital

Quarter ended September 30, 2013

Beneficial Conversion Interest Expense

Discount on Notes Payable

Additional paid in capital

NOTE 2 - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (CONTINUED)

Effect of correcting the misstatements during the three months ended December 31, 2013:

Quarter ended December 31, 2013

Stock Based Compensation

Beneficial Conversion Interest Expense

Intellectual property

Discount on Notes Payable

Additional paid in capital

Year ended December 31, 2013

Stock Based Compensation

Beneficial Conversion Interest Expense

Intellectual property

Discount on Notes Payable

Additional paid in capital

Effect on previously filed financial statements:

Quarter ended June 30, 2012

Interest (expense) income

Short - term loan - convertible

Total liabilities

Additional paid in capital

Accumulated deficit during development stage

Total stockholders' equity

Quarter ended September 30, 2012

Interest (expense) income

Short - term loan - convertible

Total liabilities

Additional paid in capital

Accumulated deficit during development stage

Total stockholders' equity

NOTE 2 - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (CONTINUED)

Year ended December 31, 2012

Interest (expense) income

Short - term loan - convertible

Total liabilities

Additional paid in capital

Accumulated deficit during development stage

Total stockholders' equity

Quarter ended March 31, 2013

Interest (expense) income

Short - term loan - convertible

Total liabilities

Additional paid in capital

Accumulated deficit during development stage

Total stockholders' deficiency

Quarter ended June 30, 2013

Operating Expense

Net loss before other expense

Interest (expense) income

Intellectual property

Short - term loan - convertible

Total liabilities

Additional paid in capital

Accumulated deficit during development stage

Total stockholders' equity

Total liabilities and stockholders' equity

Quarter ended September 30, 2013

Interest (expense) income

Total other (expense) Income

Intellectual property

Short - term loan - convertible

Total liabilities

Additional paid in capital

Accumulated deficit during development stage

Total stockholders' equity

Total liabilities and stockholders' equity

NOTE 2 - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (CONTINUED)

Development Stage

The Company is considered to be in the development stage as defined in ASC 915, “ Accounting and Reporting by Development Stage Enterprises ”.

The Company is in the development stage commencing October 1, 2011, in accordance with FASB ASC 915, Development Stage Entities.

On September 26, 2011, the Company acquired all the assets and intellectual property rights of Type 2 Defense.

1 unchanged sentence

All inventories from the former products were written off as of October 1, 2011.

The Company’s primary activities since October 1, 2011 have been performing business, strategic and financial planning, enhancing the Type2 Defense formula and securing capital for ongoing operations.

The first production run of the Company’s Type 2 Defense product was completed during June 2013.

On July 8, 2013 the Company announced their product was available for on-line sales on Amazon.com.

On July 9, 2013, the Company announced their product was available for on-line sales from our www.Type2Defense.com website.

The first sale was completed in July 2013.

As the Company only had nominal sales year ended December 31, 2013, the Company will remain in the development stage.

The Company will closely monitor their sales and determine at which point in time they will emerge from the development stage.

Use of Estimates

1 unchanged sentence

Actual results could differ from those estimates.

The Company provides estimates for its common stock valuations, inventory reserves, and valuation allowances for deferred taxes.

Currency Translation

The Company operates in Canada and the United States, and certain accounts of the Company are reflected in currencies other than the U.S.

The Company translates income and expense amounts at average exchange rates for the year, translates assets and liabilities at year-end exchange rates and equity at historical rates for currencies in the Canadian dollar.

The Company’s functional currency is the Canadian dollar, while the Company reports its currency in the US dollar.

The Company records these translation adjustments as accumulated other comprehensive income (loss).

The Company no longer operates in Canada.

Effective January 1, 2013, the Company changed its functional currency from the Canadian dollar to the US dollar and combined the accounting records into a single set of books based on the currency translation rate at January 1, 2013.

Prior to January 1, 2013, the Company recorded translation adjustments as accumulated other comprehensive income (loss).

Gains and losses from foreign currency transactions are included in other income (expense) in the results of operations.

For the years ended December 31, 2013 and 2012, the Company recorded $0 and $6,060 in translation losses, respectively.

NOTE 2 - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (CONTINUED)

Comprehensive Income (Loss)

1 unchanged sentence

Comprehensive income is a more inclusive financial reporting methodology that includes disclosure of information that historically has not been recognized in the calculation of net income.

NOTE 2 - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (CONTINUED)

Cash and Cash Equivalents

The Company considers all highly liquid debt instruments and other short-term investments with maturity of three months or less, when purchased, to be cash equivalents.

The Company maintains cash and cash equivalent balances at two financial institutions that are insured by the Federal Deposit Insurance Corporation.

Although the Company does not have any fixed assets at this point.

Any fixed assets acquired in the future will be stated at cost, less accumulated depreciation.

Depreciation will be provided using the straight-line method over the estimated useful lives of the related assets.

Costs of maintenance and repairs will be charged to expense as incurred.

Recoverability of Current and Long-Lived Assets

The Company reviews their current and long-lived assets on a periodic basis whenever events and changes in circumstances have occurred which may indicate a possible impairment.

There were no cash equivalents as of December 31, 2013 and 2012.

The Company maintains cash balances at one financial institution that is insured by the Federal Deposit Insurance Corporation.

Recoverability of Long-Lived Assets

The Company reviews their long-lived assets on a periodic basis, namely intellectual property, whenever events and changes in circumstances have occurred which may indicate a possible impairment.

The assessment for potential impairment will be based primarily on the Company’s ability to recover the carrying value of its long-lived assets from expected future cash flows from its operations on an undiscounted basis.

1 unchanged sentence

Fixed assets to be disposed of by sale will be carried at the lower of the then current carrying value or fair value less estimated costs to sell.

During the years ended December 31, 2012 and 2011, respectively, the Company wrote off their inventory for $83,508 and a pre-paid production cost for $15,700.

The Company evaluates the carrying value of goodwill during the fourth quarter of each year and between annual evaluations if events occur or circumstances change that would more likely than not reduce the fair value of the reporting unit below its carrying amount.

Such circumstances could include, but are not limited to (1) a significant adverse change in legal factors or in business climate, (2) unanticipated competition, or (3) an adverse action or assessment by a regulator.

When evaluating whether goodwill is impaired, the Company compares the fair value of the reporting unit to which the goodwill is assigned to the reporting unit’s carrying amount, including goodwill.

The fair value of the reporting unit is estimated using a combination of the income, or discounted cash flows, approach and the market approach, which utilizes comparable companies’ data.

If the carrying amount of a reporting unit exceeds its fair value, then the amount of the impairment loss must be measured.

The impairment loss would be calculated by comparing the implied fair value of reporting unit goodwill to its carrying amount.

In calculating the implied fair value of reporting unit goodwill, the fair value of the reporting unit is allocated to all of the other assets and liabilities of that unit based on their fair values.

The excess of the fair value of a reporting unit over the amount assigned to its other assets and liabilities is the implied fair value of goodwill.

We make critical assumptions and estimates in completing impairment assessments of goodwill and other intangible assets.

Our cash flow projections look several years into the future and include assumptions on variables such as future sales and operating margin growth rates, economic conditions, market competition, inflation and discount rates.

A 10% decrease in the estimated discounted cash flows for the reporting units tested would result in an impairment that is not material to our results of operations.

A 1.0 percentage point increase in the discount rate used would also result in an impairment that is not material to our results of operations.

We amortize the cost of other intangible assets over their estimated useful lives, which range up to ten years, unless such lives are deemed indefinite.

Intangible assets with indefinite lives are tested in the third quarter of each fiscal year for impairment, or more often if indicators warrant.

During the fiscal year ended December 31, 2013, the Company recorded impairment charge related to other intangible assets in the amount of $200,000.

During fiscal year 2012, we recorded no impairment charges related to other intangible assets.

Fair Value of Financial Instruments

The carrying amount reported in the balance sheets for cash and cash equivalents, accounts payable, accrued expenses, and accounts receivable approximate fair value because of the immediate or short-term maturity of these financial instruments.

The carrying amount reported in the balance sheets for cash, accounts payable, accrued expenses, and short-term notes approximate fair value because of the immediate or short-term maturity of these financial instruments.

The Company does not utilize derivative instruments.

3 unchanged sentences

ASC 470-20 requires that the beneficial conversion feature should be valued at the commitment date as the difference between the conversion price and the fair market value of the common stock into which the security is convertible, multiplied by the number of shares into which the security is convertible.

This amount is recorded as a debt discount and amortized over the life of the debt.

ASC 470-20 further limits this amount to the proceeds allocated to the convertible instrument.

14 unchanged sentences

The Company currently has no revenue.

Once the Company emerges from the development state and generates revenue from the sales of our products, the following criteria for recognition will be utilized:

Once the Company emerges from the development stage and generates revenue from the sales of our products, the following criteria for recognition will be utilized:

1) Persuasive evidence of an arrangement exists;

2 unchanged sentences

4) collectable is reasonably assured.

Share Based Compensation

The Company accounts for share-based compensation in accordance with the fair value recognition provisions of the Financial Accounting Standards Board (“FASB”) Accounting Standards Codification (“ASC”) No.

For employees, directors and non-employees, the fair value of the stock compensation is based upon the measurement date as determined at either (a) the date at which a performance commitment is reached, or (b) at the date at which the necessary performance to earn the equity instruments is complete.

The Company has not issued any stock option or warrants.

NOTE 2 - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (CONTINUED)

(Loss) Per Share of Common Stock

3 unchanged sentences

The Company has not issued any options or warrants to date.

At December 31, 2012, the total shares issuable upon conversion of convertible notes payable would be 9,349,524 shares of the Company’s common stock.

At December 31, 2013, the total shares issuable upon conversion of convertible notes payable would be approximately 10,600,000 shares of the Company’s common stock.

Inventory is stated at the lower of cost (FIFO:

1 unchanged sentence

The cost of finished goods includes the cost of packaging supplies, direct and indirect labor and other indirect manufacturing costs.

As of December 31, 2012, the Company had no inventory.

NOTE 2 - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (CONTINUED)

As of December 31, 2013, the Company had inventory of $24,879 comprise solely of the Type2Defense product.

Recent Issued Accounting Standards

In May 2011, FASB issued Accounting Standards Update (ASU) No.

2011-04, Amendments to Achieve Common Fair Value Measurement and Disclosure Requirements in U.S.

GAAP and IFRSs .

FASB ASU 2011-04 amends and clarifies the measurement and disclosure requirements of FASB ASC 820 resulting in common requirements for measuring fair value and for disclosing information about fair value measurements, clarification of how to apply existing fair value measurement and disclosure requirements, and changes to certain principles and requirements for measuring fair value and disclosing information about fair value measurements.

The new requirements are effective for fiscal years beginning after December 15, 2011.

The Company plans to adopt this amended guidance on October 1, 2012 and at this time does not anticipate that it will have a material impact on the Company’s results of operations, cash flows or financial position.

In September 2011, FASB issued ASU No.

2011-05, Presentation of Comprehensive Income , which amends the disclosure and presentation requirements of Comprehensive Income.

Specifically, FASB ASU No.

2011-05 requires that all non-owner changes in stockholders’ equity be presented either in 1) a single continuous statement of comprehensive income or 2) two separate but consecutive statements, in which the first statement presents total net income and its components, and the second statement presents total other comprehensive income and its components.

These new presentation requirements, as currently set forth, are effective for the Company beginning October 1, 2012, with early adoption permitted.

In September 2011, FASB issued ASU 2011-08, Testing Goodwill for Impairment , which amended goodwill impairment guidance to provide an option for entities to first assess qualitative factors to determine whether the existence of events or circumstances leads to a determination that it is more likely than not that the fair value of a reporting unit is less than its carrying amount.

After assessing the totality of events and circumstances, if an entity determines that it is not more likely than not that the fair value of a reporting unit is less than its carrying amount;

performance of the two-step impairment test is no longer required.

This guidance is effective for annual and interim goodwill impairment tests performed for fiscal years beginning after December 15, 2011, with early adoption permitted.

Adoption of this guidance is not expected to have any impact on the Company’s results of operations, cash flows or financial position.

In July 2012, the FASB issued ASU 2012-02, Intangibles – Goodwill and Other (Topic 350):

5 unchanged sentences

GAAP will be effective for fiscal years starting after September 15, 2012.

The Company’s adoption of this accounting guidance does not have a material impact on the consolidated financial statements and related disclosures.

The Company’s adoption of this accounting guidance does not have a material impact on the financial statements and related disclosures.

In February 2013, the FASB issued ASU 2013-05, Foreign Currency Matters (Topic 830):

Parent’s Accounting for the Cumulative Translation Adjustment upon Derecognition of Certain Subsidiaries or Groups of Assets within a Foreign Entity or of an Investment in a Foreign Entity, The standard requires that companies present either in a single note or parenthetically on the face of the financial statements, the effect of significant amounts reclassified from each component of accumulated other comprehensive income based on its source (e.g., the release due to cash flow hedges from interest rate contracts) and the income statement line items affected by the reclassification (e.g., interest income or interest expense).

If a component is not required to be reclassified to net income in its entirety (e.g., the net periodic pension cost), companies would instead cross reference to the related footnote for additional information (e.g., the pension footnote).

The amendments to U.S.

GAAP will be effective for fiscal years starting after December 15, 2012.

The Company is currently assessing the impact of this accounting guidance on the financial statements and related disclosures should be applied.

There were other updates recently issued, most of which represented technical corrections to the accounting literature or application to specific industries and are not expected to have a material impact on the Company’s financial position, results of operations or cash flows.

NOTE 3 - STOCKHOLDERS’ EQUITY (DEFICIT)

The Company was established with one class of stock, common stock – 75,000,000 shares authorized at a par value of $0.001.

On June 30, 2010, the authorized shares were increased to 90,000,000.

In October 2012, the Company increased the authorized common shares to 200,000,000.

The Company issued 870,000 unregistered shares of the Company’s stock for the three months ended March 31, 2010 to various consultants (including 450,000 shares to the CEO under the employment agreement) at a value ranging between $0.17 and $0.23 per share or $186,250.

The Company issued 672,000 unregistered shares of the Company’s stock for the three months ended June 30, 2010 to various consultants at a value ranging between $0.125 and $0.275 per share or $64,800 and 240,000 shares of stock in satisfaction of accounts payable valued at $30,000 ($0.125 per share).

On June 30, 2010, the Company approved a 1.20 to 1 stock split that increased the common shares.

The shares have been reflected retroactively herein under SAB Topic 14C.

The Company issued 750,000 unregistered shares of the Company’s stock for the three months ended September 30, 2010 to various consultants at a value ranging between $0.06 and $0.10 per share or $51,000.

The Company issued 850,000 unregistered shares of the Company’s stock for the three months ended December 31, 2010 to a consultant at a value of $0.04 per share or $34,000.

On March 27, 2011, the Company filed Form S-8 for our 2011 Stock Incentive and Equity Compensation Plan for 20,000,000 registered shares of the Company’s common stock.

We issued 15,470,000 under this plan.

During April 2011, the Company issued 1,400,000 registered shares of the Company’s common stock to two consultants for investor relations and other services compensation.

These shares were valued from $0.05 to $.055 per share or $74,617.

During April 2011, officers, directors and related parties were issued 3,000,000 registered shares of the Company’s common stock for director, officer and administrative services compensation.

These shares were valued at $0.08 per share or $240,000.

During April 2011, the Company issued 571,428 unregistered shares of the Company’s common stock to two consultants for services to the Company.

The Shares were valued from $0.07 to $0.08 per share or $42,500.

During April 2011, a related party was issued 500,000 unregistered shares of the Company’s common stock for administrative services compensation.

These shares were valued at $0.08 per share or $40,000.

During April 2011, the Company issued 320,000 registered shares of the Company’s common stock to settle a note payable.

These shares were valued at $0.021 per share or $6,806.

During April 2011, the Company issued 350,000 registered shares of the Company’s common stock to settle an account payable.

These shares were valued at $0.021 per share or $7,444.

During May 2011, the Company issued 839,951 unregistered shares of the Company’s common stock to settle two accounts payable.

These shares were valued at $0.03 per share or $25,669.

During May 2011, the Company sold 383,160 unregistered shares of the Company’s common stock for working capital.

These shares were valued at $0.03 per share or $11,480.

During May 2011, the Company issued 900,000 registered shares of the Company’s common stock to a consultant for investor relations compensation.

These shares were valued at $0.04 per share or $36,000.

During June 2011, the Company issued 900,000 registered shares of the Company’s common stock to a consultant for services to the Company.

These shares were valued at $0.03 per share or $27,000.

During July 2011, a director was issued 250,000 unregistered shares of the Company’s common stock for director compensation.

These shares were valued at $0.04 per share or $10,000.

During August 2011, the Company issued 900,000 registered shares of the Company’s common stock to a consultant for investor relations compensation.

These shares were valued at $0.025 per share or $22,500.

During September 2011, the Company issued 1,000,000 unregistered shares of the Company’s common stock to an officer as partial settlement of salary.

These shares were valued at $0.103 per share or $102,510.

During September 2011, the Company issued 2,324,600 unregistered shares of the Company’s common stock to settle three notes payable and related accrued interest.

These shares were valued from $0.094 to $0.118 per share or $247,002.

During September 2011, officers, directors and related parties were issued 7,500,000 registered shares of the Company’s common stock for director, officer and administrative services compensation.

These shares were valued at $0.015 per share or $112,500.

During September 2011, the Company issued 200,000 registered shares of the Company’s common stock to a consultant for services compensation.

These shares were valued at $0.014 per share or $2,700.

During October 2011, the Company issued 20,000,000 unregistered shares of the Company’s common stock for the acquisition of the Type 2 Defense product.

These shares were valued at $0.01 per share or $200,000.

During October 2011, the Company issued 770,000 unregistered shares of the Company’s common stock to settle accounts payable.

These shares were valued at $0.013 per share or $10,000.

During November 2011, the Company issued 600,000 unregistered shares of the Company’s common stock for the acquisition of the Type 2 Defense product.

These shares were valued at $0.011 per share or $6,600.

During December 2011, the Company issued 3,000,000 unregistered shares of the Company’s common stock to settle a note payable.

These shares were valued at $0.003 per share or $9,861.

During September and December 2011, three consultants earned 1,650,000 unregistered shares of the Company’s common stock for services to the Company.

These shares were valued from $0.01 to $0.06 per share or $41,500 and were issued on February 22, 2012.

During April 2012, the Company issued 10,000 unregistered shares of the Company’s common stock to settle a notes payable and related accrued interest.

8 unchanged sentences

These shares were valued at $0.22 per share or $5,500.

During October 2012, our chief executive officer was issued 15,000,000 unregistered shares of the Company’s common stock as part of his employment contract dated July 1, 2012.

During October 2012, our former Chief executive officer was issued 1,500,000 unregistered shares of the Company’s common stock as part of his employment contract dated July 1, 2012.

These shares were valued at $0.15 per share or $225,000.

During October and November 2012, the Company issued 1,550,000 registered shares of the Company’s common stock to a consultant for legal compensation.

During October and November 2012, the Company issued 155,000 registered shares of the Company’s common stock in their S-8 registration filed March 2011 to a consultant for legal compensation.

These shares were valued at $0.179 per share or $27,675.

1 unchanged sentence

These shares were valued at $0.09 per share or $15,375.

During November 2012, the Company issued 2,000,000 registered shares of the Company’s common stock to an employee for service to the Company.

During November 2012, the Company issued 200,000 registered shares of the Company’s common stock in their S-8 registration filed March 2011 to an employee for service to the Company.

These shares were valued at $0.125 per share or $25,000.

During November 2012, the Company issued 520,000 registered shares of the Company’s common stock to settle an accounts payable.

During November 2012, the Company issued 52,000 registered shares of the Company’s common stock in their S-8 registration filed March 2011 to settle an accounts payable.

These shares were valued at $0.121 per share or $6,300.

3 unchanged sentences

These shares were valued at $0.09 per share or $3,566.

NOTE 3 - STOCKHOLDERS’ EQUITY (DEFICIT) (CONTINUED)

During December 2012, the Company issued 57,812 unregistered shares of the Company’s common stock to settle a convertible note payable plus accrued interest.

These shares were valued at $0.09 per share or $5,228.

During January 2013, a consultant was granted 150,000 registered shares of the Company’s common stock in their S-8 registration filed in March 2013 for website services.

The shares were valued at $15,000 or $0.10 per share.

The shares were issued on March 8, 2013.

During January 2013, a consultant was granted 200,000 registered shares of the Company’s common stock in their S-8 registration filed in March 2013 for legal services to the Company.

The shares were valued at $26,000 or $0.13 per share.

The shares were issued on March 8, 2013.

During January 2013 a consultant was issued 200,000 unregistered shares of the Company’s common stock for marketing services to the Company.

These shares were valued at $26,000 or $0.13 per share.

During January 2013 a consultant was granted 50,000 unregistered shares of the Company’s common stock for accounting and finance services to the Company.

These shares were valued at $6,000 or $0.12 per share.

The shares were issued on April 23, 2013.

During January 2013, a consultant was granted 62,500 registered shares of the Company’s common stock in their S-8 registration filed March 2013 for marketing services to the Company.

The shares were valued at $6,938 or $0.111 per share.

The shares were issued on March 8, 2013.

During January 2013, a consultant was granted 450,000 registered shares of the Company’s common stock in their S-8 registration filed March 2013 for marketing services to the Company.

The shares were valued at $50,000 or $0.111 per share.

The shares were issued on March 15, 2013.

During January and February 2013, a convertible promissory note totaling $30,983 including interest was fully converted into 442,617 unregistered shares of the Company’s common stock at $0.07 per share.

During February 2013, a consultant was granted 450,000 registered shares of the Company’s common stock in their S-8 registration filed March 2013 for marketing services to the Company.

The Company issued 300,000 shares on April 23, 2013 and issued the remaining 150,000 shares on June 10, 2013 upon fulfilling certain performance obligations under the agreement.

The 300,000 shares were valued at $56,700 or $0.189 per share and the 150,000 shares were valued at $19,500 or $.13 per share for an aggregate of $76,200.

During March 2013, a consultant was granted 450,000 registered shares of the Company’s common stock in their S-8 registration filed March 2013 for marketing services to the Company.

The Company issued 300,000 shares on April 22, 2013 and issued the remaining 150,000 shares on June 10, 2013 upon fulfilling certain performance obligations under the agreement.

The 300,000 shares were valued at $69,000 or $0.23 per share and the 150,000 shares were valued at $19,500 or $.13 per share for an aggregate of $88,500.

On March 4, 2013, the Company filed a Form S-8 with the Security and Exchange Commission.

The 2013 Stock Incentive Plan may issue up to 30,000,000 registered shares of the Company’s common stock for services to the Company.

The Company granted 25,625,000 (2,562,500 post reverse split shares) shares under this plan during the year ended December 31, 2013.

During March 2013, a convertible promissory note was partially converted into unregistered shares of the Company’s common stock.

The amount totaled $3,091 including interest was converted into 44,158 unregistered shares of the Company’s common stock at $0.07 per share.

During March 2013, a convertible promissory notes totaling $4,433.61 including interest was fully converted into 177,344 unregistered shares of the Company’s common stock at $0.025 per share.

The shares were issued on April 3, 2013.

NOTE 3 - STOCKHOLDERS’ EQUITY (DEFICIT) (CONTINUED)

During April 2013, the Company issued 50,000 registered shares of the Company’s common stock in their S-8 registration filed March 2013 to settle an accounts payable.

These shares were valued at $0.128 per share or $6,375.

During April 2013, a convertible promissory note was converted into unregistered shares of the Company’s common stock.

The amount totaled $10,266 including interest was converted into 146,654 unregistered shares of the Company’s common stock at $0.07 per share.

During May 2013 a consultant was granted 10,000 unregistered shares of the Company’s common stock for investor relation services to the Company.

These shares were valued at $1,410 or $0.141 per share.

During May 2013, a convertible promissory note was converted into unregistered shares of the Company’s common stock.

The amount totaled $7,175 including interest was converted into 102,500 unregistered shares of the Company’s common stock at $0.07 per share.

During June 2013, a director was issued 250,000 unregistered shares of the Company’s common stock for marketing services compensation.

These shares were valued at $0.15 per share or $37,500.

During June 2013, an employee was issued 350,000 unregistered shares of the Company’s common stock for website services and salary compensation.

These shares were valued at $0.15 per share or $52,500.

During June 2013, a consultant was issued 250,000 unregistered shares of the Company’s common stock for warehousing and fulfillment services compensation.

These shares were valued at $0.15 per share or $37,500.

During June 2013, our former Chief executive officer was issued 1,500,000 unregistered shares of the Company’s common stock for fulfilling provisions in the Type2 acquisition agreement dated September 26, 2011.

These shares were valued at $0.15 per share or $225,000.

During June 2013, a consultant was issued 250,000 unregistered shares of the Company’s common stock for investor relations compensation.

These shares were valued at $0.15 per share or $37,500.

During July 2013, a convertible promissory note was converted into unregistered shares of the Company’s common stock.

The amount totaled $7,688 including interest was converted into 153,750 unregistered shares of the Company’s common stock at $0.05 per share.

During August 2013, a consultant was granted 750,000 registered shares of the Company’s common stock in their S-8 registration filed March 2013 for marketing services and creating an infomercial for the Company.

The shares were valued at $75,000 or $0.10 per share.

During August 2013, a convertible promissory note was converted into unregistered shares of the Company’s common stock.

The amount totaled $12,500 was converted into 125,000 unregistered shares of the Company’s common stock at $0.10 per share.

During September 2013, a convertible promissory note was converted into unregistered shares of the Company’s common stock.

The amount totaled $7,688 including interest was converted into 153,750 unregistered shares of the Company’s common stock at $0.05 per share.

NOTE 3 - STOCKHOLDERS’ EQUITY (DEFICIT) (CONTINUED)

During September 2013, a third party purchased a $12,000 demand promissory note dated January 25, 2013 from one of the Company’s investors.

According to the release and settlement between the Company and the third party, the note may be converted into unregistered shares of the Company’s common stock for $.01 per share.

The third party partially converted $6,000 of the demand promissory note into 600,000 unregistered shares of the Company’s common stock at $0.01 per share.

In addition, the Company recorded a loss on conversion of debt for $21,000 in the accompanying statements of operations for the difference between the fair market value to the Company’s common stock and the conversion price.

The fair market value on the date of conversion was $0.045 per share.

During November 2013, a convertible promissory note was converted into unregistered shares of the Company’s common stock.

On November 7, 2013, the Company agreed to modify the terms of the convertible promissory note to reduce the conversion price from $0.10 per share and to $0.015 per share.

The amount totaled $10,750 including interest was converted into 716,667 unregistered shares of the Company’s common stock at $0.015 per share.

During December 2013, a convertible promissory note was converted into unregistered shares of the Company’s common stock.

On November 7, 2013, the Company agreed to modify the terms of the convertible promissory note to reduce the conversion price from $0.05 per share and to $0.015 per share.

The amount totaled $10,189 including interest was converted into 679,251 unregistered shares of the Company’s common stock at $0.015 per share.

During December 2013, a consultant was granted 800,000 unregistered shares of the Company’s common stock for a clinical research study on our Type2Defense product.

These shares were valued at $0.018 per share or $14,400.

The shares were issued in January 2014.

As of December 31, 2013, the Company has 18,872,777 shares of common stock issued and outstanding.

The Company has not issued any options or warrants to date.

NOTE 4 - RELATED PARTY TRANSACTIONS

The Company conducts business with another company owned by a former officer of the Company.

The Company uses office space in the other company’s offices.

For the years ended December 31, 2012 and 2011 the Company incurred $0 and $4,104, respectively, for rent expense to this company.

NOTE 4 - SHORT-TERM LOANS

On January 25, 2013, the Company issued a $12,000 promissory note to an individual.

The loan bears interest at 5% and is payable on demand.

On September 24, 2013, the note was sold to a third party and the accrued interest was forgiven.

According to the release and settlement between the Company and the third party, the note may be converted into unregistered shares of the Company’s common stock for $.01 per share.

The third party converted $6,000 of the note into 600,000 unregistered shares of the Company’s common stock for $.01 per share.

The fair market value on the date of conversion was $0.045 per share.

The unpaid balance was $6,000 at December 31, 2013.

This note is included as short - term loans on the balance sheet.

NOTE 5 - SHORT-TERM LOANS – RELATED PARTY

4 unchanged sentences

NOTE 6 - CONVERTIBLE NOTES PAYABLE

On March 27, 2009, the Company entered into a promissory note payable on demand for $10,000 (CD$).

The note accrued interest at 5% per annum.

On November 30, 2012, the Company amended the note to add a conversion feature that permits the holder, at any time, to convert the note into shares of the Company’s common stock at an exercise price of $.0025 per share.

As part of the new agreement, the holder of the note waived all interest including interest previously accrued.

During December 2011, $7,500 CAD was converted into 3,000,000 shares of the Company’s common stock at $0.0025 per share.

During December 2012 the remaining $2,500 CAD was converted into 1,000,000 registered shares of the Company’s common stock at $0.0025 per share to fully satisfy the promissory note.

On April 9, 2009, the Company entered into a promissory note payable on demand for $10,000 (CD$).

The note accrued interest at 5% per annum.

On April 30, 2012, the Company amended the note to add a conversion feature that permits the holder, at any time, to convert the note into shares of the Company’s common stock at an exercise price of $.0025 per share.

As part of the new agreement, the holder of the note waived all interest including interest previously accrued.

During November and December 2012, $10,000 CAD was converted into 4,000,000 registered shares of the Company’s common stock at $0.0025 per share to fully satisfy the promissory note.

On December 16, 2011, the Company was advanced $4,100 each from two unrelated parties.

1 unchanged sentence

In addition, at any time, the holders may convert the notes into shares of the Company’s common stock at an exercise price of $.025 per share.

During July and September 2012, one of the convertible notes was converted into 1,000,000 unregistered shares and 640,000 registered shares of the Company’s common stock, respectively, at $0.0025 per share.

The unpaid balance including accrued interest was $4,314 and $8,218 at December 31, 2012 and December 31, 2011, respectively.

On March 31, 2012, the Company issued a $15,000 convertible note to an individual.

The Company calculated the fair value of the beneficial conversion feature as the difference between the conversion price and the fair market value of the Company’s common stock into on the date of issuance.

The fair value of the conversion option in connection with the note on the date of issuance aggregated $8,200, and was recorded as debt discount.

The debt discount was amortized through the term of the note.

During July and September 2012, one of the convertible notes was converted into 164,000 unregistered shares of the Company’s common stock at $0.025 per share.

During March 2013 the remaining $4,434, principle and accrued interest was converted into 177,344 unregistered shares of the Company’s common stock at $0.025 per share to fully satisfy the promissory note.

On April 20, 2012, the Company issued a $2,500 convertible note to an individual.

The loan bears interest at 5% and has a maturity date of October 20, 2012.

In addition, at any time, the holder may convert the note into shares of the Company’s common stock at an exercise price of $0.009 per share.

After the due date, the interest rate on the convertible note increased to 15%.

The fair value of the conversion option in connection with the note on the date of issuance aggregated $2,083, and was recorded as debt discount.

The debt discount was amortized through the term of the note.

The unpaid balance including accrued interest was $3,016 and $2,641 at December 31, 2013 and 2012, respectively.

The Company is not compliant with the repayment terms of the note.

On May 10, 2012, the Company issued a $2,600 convertible note to the Company’s former CEO.

The loan bears interest at 5% and has a maturity date of November 10, 2012.

In addition, at any time, the Company’s former CEO may convert the note into shares of the Company’s common stock at an exercise price of $0.009 per share.

After the due date, the interest rate on the convertible note increases to 15%.

The fair value of the conversion option in connection with the note on the date of issuance aggregated $1,733, and was recorded as debt discount.

The debt discount was amortized through the term of the note.

During June 2013, the Company paid the principal balance of $2,600 to the Company’s former CEO.

The unpaid balance including accrued interest of $2,714 was in default at December 31, 2012.

On July 18, 2012, the Company issued a $30,000 convertible note to an individual.

The loan bears interest at 5% and has a maturity date of December 18, 2012.

In addition, at any time, the individual may convert the note into shares of the Company’s common stock at an exercise price of $0.07 per share.

The fair value of the conversion option in connection with the note on the date of issuance aggregated $30,000, and was recorded as debt discount.

The debt discount was amortized through the term of the note.

During January and February 2013, $30,983 including accrued interest was converted into 442,617 unregistered shares of the Company’s common stock at $0.07 per share to fully satisfy the promissory note.

The unpaid balance including accrued interest of $30,813 was in default at December 31, 2012.

On August 22, 2012, the Company issued a $3,000 convertible note to an individual.

The loan bears interest at 5% and has a maturity date of January 22, 2013.

In addition, at any time, the individual may convert the note into shares of the Company’s common stock at an exercise price of $0.07 per share.

The fair value of the conversion option in connection with the note on the date of issuance aggregated $10,000, and was recorded as debt discount.

The debt discount was amortized through the term of the note.

During March 2013, $3,091 including accrued interest was converted into 44,158 unregistered shares of the Company’s common stock at $0.07 per share to fully satisfy the promissory note.

The unpaid balance including accrued interest was $3,056 at December 31, 2012.

NOTE 6 - CONVERTIBLE NOTES PAYABLE (CONTINUED)

On October 19, 2012, the Company issued a $10,000 convertible note to an individual.

The loan bears interest at 5% and has a maturity date of April 19, 2013.

In addition, at any time, the individual may convert the note into shares of the Company’s common stock at an exercise price of $0.07 per share.

The fair value of the conversion option in connection with the note on the date of issuance aggregated $3,000, and was recorded as debt discount.

The debt discount was amortized through the term of the note.

During April 2013, $10,266 including accrued interest was converted into 146,654 unregistered shares of the Company’s common stock at $0.07 per share to fully satisfy the promissory note.

The unpaid balance including accrued interest was $10,105 at December 31, 2012.

On November 23, 2012, the Company issued a $7,000 convertible note to an individual.

The loan bears interest at 5% and has a maturity date of May 23, 2013.

In addition, at any time, the individual may convert the note into shares of the Company’s common stock at an exercise price of $0.07 per share.

The fair value of the conversion option in connection with the note on the date of issuance aggregated $5,500, and was recorded as debt discount.

The debt discount was amortized through the term of the note.

During May 2013, $7,175 including accrued interest was converted into 102,500 unregistered shares of the Company’s common stock at $0.07 per share to fully satisfy the promissory note.

The unpaid balance including accrued interest was $7,037 at December 31, 2012.

On January 28, 2013, the Company issued a $12,500 convertible note to an individual.

The loan bears interest at 5% and is payable on demand and may be converted at any time prior to December 31, 2013 into shares of the Company’s common stock.

The conversion price shall be 80% of the average closing price of the stock for the ten (10) business days preceding the conversion notice.

The conversion price shall not be lower than $0.10 per share.

The fair value of the conversion option in connection with the note on the date of issuance aggregated $8,508, and was recorded as debt discount.

The debt discount was amortized through the term of the note.

During August 2013, $12,500 was converted into 125,000 unregistered shares of the Company’s common stock at $0.10 per share to satisfy the principal balance of the promissory note.

The unpaid balance of accrued interest was $328 at December 31, 2013.

On January 30, 2013, the Company issued a $7,500 convertible note to an individual.

The loan bears interest at 5% and has a maturity date of July 30, 2013.

In addition, at any time, the holder may convert the note into shares of the Company’s common stock at an exercise price of $.05 per share.

During October 2012, $15,000 plus $375 for accrued interest was converted into 1,708,334 registered shares of the Company’s common stock at $0.009 per share to fully satisfy the promissory note.

The fair value of the conversion option in connection with the note on the date of issuance aggregated $7,500, and was recorded as debt discount.

The debt discount was amortized through the term of the note.

During August 2013, $7,688 including accrued interest was converted into 153,750 unregistered shares of the Company’s common stock at $0.05 per share to fully satisfy the promissory note.

On February 20, 2013, the Company issued a $7,500 convertible note to an individual.

The loan bears interest at 5% and has a maturity date of August 20, 2013.

In addition, at any time, the holder may convert the note into shares of the Company’s common stock at an exercise price of $0.05 per share.

The fair value of the conversion option in connection with the note on the date of issuance aggregated $7,500, and was recorded as debt discount.

The debt discount was amortized through the term of the note.

During September 2013, $7,688 including accrued interest was converted into 153,750 unregistered shares of the Company’s common stock at $0.05 per share to fully satisfy the promissory note.

On February 26, 2013, the Company issued a $12,500 convertible note to an individual.

The loan bears interest at 5% and is payable on demand and may be converted at any time prior to January 31, 2014 into shares of the Company’s common stock.

The conversion price shall be 80% of the average closing price of the stock for the ten (10) business days preceding the conversion notice.

The conversion price shall not be lower than $0.01 per share.

The fair value of the conversion option in connection with the note on the date of issuance aggregated $1,705, and was recorded as debt discount.

The debt discount was amortized through the term of the note.

The unpaid balance including accrued interest was $13,021 at December 31, 2013.

NOTE 6 - CONVERTIBLE NOTES PAYABLE (CONTINUED)

On April 30, 2013, the Company issued a $10,000 convertible note to an individual.

1 unchanged sentence

In addition, at any time, the holder may convert the note into shares of the Company’s common stock at an exercise price of $0.05 per share.

The unpaid balance including accrued interest was $2,641 at December 31, 2012.

The fair value of the conversion option in connection with the note on the date of issuance aggregated $10,000, and was recorded as debt discount.

The debt discount was amortized through the term of the note.

On November 7, 2013, the Company agreed to modify the terms of the convertible promissory note to reduce the conversion price from $0.05 per share and to $0.015 per share.

During November 2013, $10,750 including accrued interest was converted into 716,667 unregistered shares of the Company’s common stock at $0.015 per share to fully satisfy the promissory note.

On April 30, 2013, the Company issued a $10,000 convertible note to an individual.

1 unchanged sentence

In addition, at any time, the holder may convert the note into shares of the Company’s common stock at an exercise price of $0.10 per share.

During December 2012, $5,000 plus $228 for accrued interest was converted into 578,120 registered shares of the Company’s common stock at $0.009 per share to fully satisfy the promissory note.

On May 10, 2012, the Company issued a $2,600 convertible note to the Company’s CFO.

The loan bears interest at 5% and has a maturity date of November 15, 2012.

In addition, at any time, the Company’s CFO may convert the note into shares of the Company’s common stock at an exercise price of $.009 per share.

The unpaid balance including accrued interest was $2,714 at December 31, 2012.

The fair value of the conversion option in connection with the note on the date of issuance aggregated $4,800, and was recorded as debt discount.

The debt discount was amortized through the term of the note.

On November 7, 2013, the Company agreed to modify the terms of the convertible promissory note to reduce the conversion price from $0.10 per share to $0.015 per share.

During December 2013, $10,189 including accrued interest was converted into 679,251 unregistered shares of the Company’s common stock at $0.015 per share to fully satisfy the promissory note.

In addition, the fair value of the conversion option in connection with the note on the date of modification aggregated $5,200, and was recorded as debt discount.

Since the note was past due and in default, the debt discount was recognized as interest expense on the date of modification.

On May 27, 2013, the Company issued a $12,500 convertible note to an individual.

The loan bears interest at 5% and has a maturity date of November 27, 2013.

In addition, at any time, the individual may convert the note into shares of the Company’s common stock at an exercise price of $.009 per share.

During December 2012, $3,500 plus $166 for accrued interest was converted into 399,011 registered shares of the Company’s common stock at $0.009 per share to fully satisfy the promissory note.

On July 18, 2012, the Company issued a $30,000 convertible note to an individual.

In addition, at any time, the holder may convert the note into shares of the Company’s common stock at an exercise price of $.005 per share.

The fair value of the conversion option in connection with the note on the date of issuance aggregated $12,500, and was recorded as debt discount.

The debt discount was amortized through the term of the note.

The unpaid balance including accrued interest was $12,865 at December 31, 2013.

The Company is not compliant with the repayment terms of the note and currently in default.

On June 11, 2013, the Company issued a $6,500 convertible note to an individual.

The loan bears interest at 5% and has a maturity date of August 11, 2013.

In addition, at any time, the holder may convert the note into shares of the Company’s common stock at an exercise price of $.0065 per share.

The fair value of the conversion option in connection with the note on the date of issuance aggregated $2,500, and was recorded as debt discount.

The debt discount was amortized through the term of the note.

The unpaid balance including accrued interest was $6,676 at December 31, 2013.

The Company is not compliant with the repayment terms of the note and currently in default.

On June 11, 2013, the Company issued a $6,222 convertible note to an individual.

The loan bears interest at 5% and has a maturity date of August 11, 2013.

In addition, at any time, the holder may convert the note into shares of the Company’s common stock at an exercise price of $.0065 per share.

The fair value of the conversion option in connection with the note on the date of issuance aggregated $2,393, and was recorded as debt discount.

The debt discount was amortized through the term of the note.

The unpaid balance including accrued interest was $6,391 at December 31, 2013.

The Company is not compliant with the repayment terms of the note and currently in default.

NOTE 6 - CONVERTIBLE NOTES PAYABLE (CONTINUED)

On June 11, 2013, the Company issued a $6,500 convertible note to an individual.

The loan bears interest at 5% and has a maturity date of August 11, 2013.

In addition, at any time, the holder may convert the note into shares of the Company’s common stock at an exercise price of $.0065 per share.

The fair value of the conversion option in connection with the note on the date of issuance aggregated $2,500, and was recorded as debt discount.

The debt discount was amortized through the term of the note.

The unpaid balance including accrued interest was $6,676 at December 31, 2013.

The Company is not compliant with the repayment terms of the note and currently in default.

On June 18, 2013, the Company issued a $12,500 convertible note to an individual.

The loan bears interest at 5% and has a maturity date of December 18, 2013.

In addition, at any time, the individual may convert the note into shares of the Company’s common stock at an exercise price of $.007 per share.

In addition, at any time, the holder may convert the note into shares of the Company’s common stock at an exercise price of $.005 per share.

The fair value of the conversion option in connection with the note on the date of issuance aggregated $12,500, and was recorded as debt discount.

The debt discount was amortized through the term of the note.

The unpaid balance including accrued interest was $12,839 at December 31, 2013.

The Company is not compliant with the repayment terms of the note and currently in default.

On August 2, 2013, the Company issued a $10,000 convertible note to an individual.

The loan bears interest at 5% and has a maturity date of January 22, 2013.

In addition, at any time, the individual may convert the note into shares of the Company’s common stock at an exercise price of $.007 per share.

The loan bears interest at 5% and has a maturity date of February 2, 2014.

In addition, at any time, the holder may convert the note into shares of the Company’s common stock at an exercise price of $.005 per share.

The fair value of the conversion option in connection with the note on the date of issuance aggregated $11,000, and was recorded as debt discount.

The debt discount was amortized through the term of the note.

The unpaid balance including accrued interest was $10,208 at December 31, 2013.

The Company is not compliant with the repayment terms of the note and currently in default.

On December 10, 2013, the Company issued a $3,000 convertible note to an individual.

The loan bears interest at 5% and has a maturity date of June 10, 2014.

In addition, at any time, the holder may convert the note into shares of the Company’s common stock at an exercise price of $0.015 per share.

The fair value of the conversion option in connection with the note on the date of issuance aggregated $10,000, and was recorded as debt discount.

The debt discount is amortized through the term of the note.

The unpaid balance including accrued interest was $3,009 at December 31, 2013.

On December 10, 2013, the Company issued a $5,000 convertible note to an individual.

The loan bears interest at 5% and has a maturity date of June 10, 2014.

In addition, at any time, the holder may convert the note into shares of the Company’s common stock at an exercise price of $0.015 per share.

The fair value of the conversion option in connection with the note on the date of issuance aggregated $10,000, and was recorded as debt discount.

The debt discount is amortized through the term of the note.

The unpaid balance including accrued interest was $5,014 at December 31, 2013.

As of December 31, 2013, the total short-term loans - convertible amounted to $80,043 including $2,821 of accrued interest.

The conversion price of the notes were fixed and determinable on the date of issuance and as such in accordance with ASC Topic 815 “ Derivatives and Hedging ” (“ASC 815”), the embedded conversion options of the note were not considered derivative liabilities.

The beneficial conversion features of the convertible notes are at a price below fair market value.

The Company recorded interest expense of $34,296 year ended December 31, 2012, in the accompanying statement of operations for the beneficial conversion feature based on the fair market value of $0.01 per share of the Company’s common stock at December 31, 2012.

NOTE 7 - MAJOR CUSTOMERS

The Company generated no sales during the year ended December 31, 2012 and 2011.

The beneficial conversion features of certain convertible notes are at a price below fair market value.

The Company recorded interest expense on the debt discount of $96,864 and $34,496 for the years ended December 31, 2013 and 2012, respectively.

In addition, the out-of-period adjustment at December 31, 2013 for the improperly valued beneficial conversion option of the Company’s convertible notes payable was a charge to interest expense of $58,272 (see Note 2 in the Notes to the Financial Statements)

NOTE 7 - PROVISION FOR INCOME TAXES

2 unchanged sentences

Deferred tax assets and liabilities are recognized based on anticipated future tax consequences attributable to differences between financial statement carrying amounts of assets and liabilities and their respective tax bases.

As of December 31, 2012, there is no provision for income taxes, current or deferred.

Net operating losses

Valuation allowance

At December 31, 2012, the Company had a net operating loss carry forward in the amount of $3,442,575, available to offset future taxable income.

The income tax provision (benefit) consists of the following:

State and local

Change in valuation allowance

Income tax provision (benefit)

At December 31, 2013 and 2012, the Company had a net operating loss (“NOL’s”) carry forward in the amount of $4,901,721 and $3,442,575, respectively, available to offset future taxable income.

The Company established valuation allowances equal to the full amount of the deferred tax assets due to the uncertainty of the utilization of the operating losses in future periods.

The Company has not filed its federal tax returns since inception and therefore, the NOL’s will not be available to offset future taxable income until the tax returns are filed with the respective federal tax authorities.

A reconciliation of the Company’s effective tax rate as a percentage of income before taxes and federal statutory rate for the periods ended December 31, 2013 and 2012 is summarized below.

3 unchanged sentences

NOTE 8 - CONVERSION OF ACCOUNTS PAYABLE AND NOTES PAYABLE TO EQUITY

On September 11, 2008, the Company entered into a License Agreement with Oceanutrasciences Inc., a Canadian company (“ONS”) (the “Agreement”)/ The Agreement is for a term of three years from September 11, 2008 to September 11, 2011.

Under the terms of the Agreement, the Company has acquired the license and trademark rights to produce the “Nutra-Pro 80-20” product from ONS in the North America animal feed territory.

The Company has acquired these rights for $150,000 (CD$) ($141,525 US$ at September 11, 2008).

The Company paid the initial payment of $50,000 (CD$), with the remaining payments due $50,000 (CD$) on October 31, 2008 and $50,000 (CD$) on December 31, 2008.

The Company has made a $25,000 (CD$) payment in December 2008, and as of December 31, 2009 and through November 26, 2010 owed $75,000 (CD$), which was reflected in accounts payable and accrued expenses on the balance sheet as of December 31, 2010.

On November 26, 2010, ONS has filed bankruptcy in Canada.

ONS has sold their assets to another company.

The Company was amortizing the license fee over the 36 month term of the Agreement.

Amortization expense for the year ended December 31, 2010 was $48,541.

The remaining $34,967 of unamortized license fees has been deemed impaired by Management as of December 31, 2010.

On May 15, 2012, the Company obtained a legal opinion that the $75,000 (CD$) balance due to ONS should not be recognized as an amount owed by Bio-Solutions and may be written off at December 31, 2011.

The legal opinion contains a four part justification, first, the contract was never fulfilled by ONS, second, the September 20, 2009 ONS bankruptcy documents did not recognize the $75,000 (CD$) as an asset of ONS, third, subsection 10.1 of the Agreement provides for the right of one party to request the Agreement be resiliated in the event one party files for bankruptcy and finally, the contractual prescription in the province of Quebec, Canada, for similar contracts is three (3) years.

At December 31, 2011, the Company wrote-off the $73,748 (US$) as a conversion of accounts payable to equity.

On June 15, 2012, Gilles Chaumillon resigned as President, Chief Executive Officer and Director of the Company.

1 unchanged sentence

Chaumillon agreed to settle his outstanding debt, interest and account payable balances of $227,811 for $10,000 payable in ten equal monthly installments of $1,000 beginning July 2012.

At June 30, 2012, the Company wrote-of the net amount of $217,811 as a conversion of accounts payable and notes payable to equity.

At June 30, 2012, the Company wrote-off the net amount of $217,811 as a conversion of accounts payable and notes payable to equity.

At December 31, 2013, Mr.

6 unchanged sentences

On November 4, 2011, an advance of 60,000 shares of the Company’s common stock related to the reaching of 1,500 customers’ milestone in the original agreement was approved by the board of directors.

The shares were valued at $0.013 per share or $6,600 and included as intellectual property on the accompanying condensed balance sheet.

The shares were valued at $0.13 per share or $6,600.

The issuance of 10,000,000 shares of the Company’s common stock upon reaching 1,500 customers was reduced by the advance to 940,000 shares.

As of March 22, 2013, the agreement provisions for achieving operational milestones for 10,000,000 shares of the Company’s common stock and reaching 1,500 customers for 9,400,000 shares of the Company’s common stock have not been achieved.

All assets other than the intellectual property had a fair value of $0, with the intellectual property being valued at $206,600.

The Company has not amortized this value as they deem the value to have an infinite useful life.

The Company performed an impairment test as of December 31, 2012 and concluded that based on discounted cash flows for the Type 2 product, the related intellectual property asset for $206,600 was not impaired.

During June 2013, the Company achieved the operational milestones as specified in the September 26, 2011 Type 2 Defense acquisition agreement.

On June 18, 2013, the Company issued 1,000,000 shares to the Company’s former CEO for the Type2 Defense product meeting the operational milestones.

The shares were valued at $0.15 per share or $150,000 and included as stock based compensation in the accompanying statement of operation.

In addition, on June 18, 2013, an advance of 500,000 shares of the Company’s common stock related to reaching of 1,500 customers milestone in the original agreement was approved by the board of directors and issued to the Company’s former CEO.

The shares were valued at $0.15 per share or $75,000 and included as stock based compensation in the accompanying statement of operation.

As of June 20, 2014 the agreement provisions for reaching 1,500 customers for 440,000 shares of the Company’s common stock has not been achieved.

All assets other than the intellectual property had a fair value of $0, with the intellectual property was valued at $200,000.

Since the Company has not been able to generate substantial revenues from our Type2Defense product over the last two years and have only produced minimal sales of the product in 2014, the Company elected to write-off the $200,000 intellectual property for Type2Defense as impaired.

NOTE 10 - FAIR VALUE MEASUREMENTS

13 unchanged sentences

NOTE 11 - SUBSEQUENT EVENTS

During January 2013, the Company signed an agreement with a consultant for website services.

The terms of the agreement include a fee of $15,000 or 1,500,000 registered shares of the Company’s common stock in their S-8 registration filed March 2013.

The shares were valued at $0.01 per share.

The shares were issued on March 8, 2013.

During January 2013, a consultant was granted 2,000,000 registered shares of the Company’s common stock in their S-8 registration filed March 2013 for legal services to the Company.

The shares were valued at $0.013 per share or $26,000.

The shares were issued on March 8, 2013.

During January 2013 a consultant was issued 2,000,000 unregistered shares of the Company’s common stock for marketing services to the Company.

During January 2014, our former chief executive officer canceled 600,000 of his personal unregistered shares of the Company’s common stock to satisfy a promissory note conversion request.

These shares were valued at $0.035 per share or $21,000.

During January 2013, a consultant was granted 625,000 registered shares of the Company’s common stock in their S-8 registration filed March 2013 for marketing services to the Company.

The shares were valued at $0.011 per share or $6,875.

The shares were issued on March 8, 2013.

During January, 2013, the Company issued a $12,000 promissory note to an individual.

The loan bears interest at 5% and is payable on demand.

During January 2013, a consultant was granted 4,500,000 registered shares of the Company’s common stock in their S-8 registration filed March 2013 for marketing services to the Company.

The shares were valued at $0.011 per share or $50,000.

The shares were issued on March 15, 2013.

During January 2013, the Company issued a $12,500 convertible note to an individual.

The loan bears interest at 5% and is payable on demand and may be converted at any time prior to December 31, 2013 into shares of the Company’s common stock.

The conversion price shall be 80% of the average closing price of the stock for the ten (10) business days preceding the conversion notice.

The conversion price shall not be lower than $0.01 per share.

This transaction will result in the recording a derivative liability in the Company’s financial statements during the Quarter ended March 31, 2013.

During January 2013, the Company issued a $7,500 convertible note to an individual.

The loan bears interest at 5% and has a maturity date of July 30, 2013.

During January 2014, a promissory note was converted into unregistered shares of the Company’s common stock.

The amount totaled $12,849 including interest was converted into 856,632 unregistered shares of the Company’s common stock at $0.015 per share.

On January 6, 2014, the Company agreed to modify the terms of this $12,500 convertible promissory notes dated May 27, 2013.

The conversion rate was reduced from $0.05 per share to $0.015 per share.

During March 2014, a promissory note was partially converted into unregistered shares of the Company’s common stock.

The amount totaled $4,000 was converted into 800,000 unregistered shares of the Company’s common stock at $0.005 per share.

During March 2014, a promissory note was converted into unregistered shares of the Company’s common stock.

The amount totaled $13,151 including interest was converted into 658,594 unregistered shares of the Company’s common stock at $0.020 per share.

During March 2014, the Company signed an agreement with a firm to provide strategic business development activities for the Company.

The firm will be compensated with 360,000 unregistered shares of the Company’s common stock payable in increments of 30,000 shares per month for twelve (12) months starting on April 1, 2014.

As of June 20, the Company issued 90,000 unregistered shares of the Company’s common stock which were valued at $0.014 per share or $1,239.

On April 7, 2014, the Company terminated the Marketing Services Agreement Dated July 24, 2013 between the Company and Damon R Devitt to produce an infomercial for the Type2Defense product.

The Company acknowledges that the infomercial stated in the Marketing Services Agreement dated July 24, 2013 has been completed, but the Company does not desire to complete a media placement using the infomercial or use this infomercial for any benefit to the Company.

The Company has resolved to move in a different direction for marketing the Type2Defense product.

In addition, the Company acknowledges is owes Mr.

Devitt 7,500,000 S-8 shares for completing the infomercial, which must be adjusted for the Company’s 1 for 10 reverse split declared effective on February 26, 2014.

Thus, the Company issued 750,000 S-8 shares (7,500,000 / 10) to Mr.

Devitt at $.0151 per share on April 15, 2014.

On April 8, 2014, the Company appointed James Hodge as Chairmen of the Company’s board of directors.

On April 8, 2014, in a special meeting of the board of directors, the board voted in favor of amending the Company’s Bylaws to decrease the number of members of the board of directors from three to one.

Gallagher and Metzger agreed to resign from the board and accept other duties for the Company as follows:

William Gallagher, Chief Executive Officer and director elected to retire from the Company.

Gallagher signed a twenty four (24) month advisory agreement to promote the Company’s product(s), introduce new products and to provide capital formation initiatives.

Gallagher will be compensated with a $2,500 monthly fee (an aggregate of $60,000).

In addition, Mr.

Gallagher will receive a 10% commission on the collections of sales he consummates.

NOTE 11 - SUBSEQUENT EVENTS (CONTINUED)

Metzger, PhD , President, Chief Operating Officer and director resigned from the Company’s board of directors .

Metzger signed a twelve (12) month consulting agreement to continue as the Company’s President.

Metzger will receive Two Hundred and Fifty Thousand (250,000) unregistered shares of the Company’s common stock in consideration for prior services rendered to the Company.

In addition, the Company agreed to pay Mr.

Metzger $18,000 for the twelve month consulting period.

In lieu of cash, the Company will issue unregistered shares of the Company’s common stock at September 4, 2014 equal to $18,000 with a cap of 250,000 unregistered shares of the Company’s common stock which shall be determined based on the average closing price of the Company’s common stock, as publicly traded, during the last five (5) business days prior to September 8, 2014.

On April 8, 2014, the Company issued a $21,000 convertible note to an individual.

The loan bears interest at 8% and has a maturity date of October 8, 2014.

In addition, at any time, the holder may convert the note into shares of the Company’s common stock at an exercise price of $.0065 per share.

During February, 2013, the Company issued a $7,500 convertible note to an individual.

The loan bears interest at 5% and has a maturity date of August 20, 2013.

On April 21, 2014, the Company promoted Thomas Metzger PhD, President to Chief Executive Officer and Chief Financial Officer.

In addition, Peggy Knight, Executive Vice-President of Marketing was promoted to Chief Marketing Officer.

During April 2014, our former chief executive officer was re-issued 600,000 unregistered shares of the Company’s common stock which were canceled in January 2014 to satisfy a promissory note conversion request.

These shares were valued at $0.035 per share or $21,000.

During April 2014, Thomas Metzger, our chief executive officer/chief financial officer was issued 250,000 unregistered shares of the Company’s common stock for compensation.

These shares were valued at $0.0151 per share or $3,375.

During April 2014, James Hodge, our chairman of the board of directors, was issued 250,000 unregistered shares of the Company’s common stock for joining the Company’s board.

These shares were valued at $0.0151 per share or $3,375.

During April 2014, Peggy Knight our chief marketing officer was issued 750,000 unregistered shares of the Company’s common stock for marketing compensation.

These shares were valued at $0.0151 per share or $11,325.

On May 8, 2014, the Company issued a $21,000 convertible note to an individual.

The loan bears interest at 8% and has a maturity date of November 8, 2014.

In addition, at any time, the holder may convert the note into shares of the Company’s common stock at an exercise price of $.0065 per share.

During January and February 2013, convertible promissory notes totaling $30,983 including interest was fully converted into 4,426,174 unregistered shares of the Company’s common stock at $0.007 per share.

During February 2013, the Company issued a $12,500 convertible note to an individual.

The loan bears interest at 5% and is payable on demand and may be converted at any time prior to January 31, 2014 into shares of the Company’s common stock.

The conversion price shall be 80% of the average closing price of the stock for the ten (10) business days preceding the conversion notice.

The conversion price shall not be lower than $0.01 per share.

This transaction will result in the recording a derivative liability in the Company’s financial statements during the Quarter ended March 31, 2013.

During February 2013, the Company began the first production run of the Type 2 Defense product.

The product will completed in in May 2013 with sales expected in May and June 2013.

During March 2013, the Company filed a Form S-8 with the Security and Exchange Commission.

The 2013 Stock Incentive Plan may issue up to 30,000,000 registered shares of the Company’s common stock for services to the Company.

On May 28, 2014, the Company issued a $10,000 convertible note to an individual.

The loan bears interest at 5% and has a maturity date of November 28, 2014.

In addition, at any time, the holder may convert the note into shares of the Company’s common stock at an exercise price of $.0065 per share.

Changes in and Disagreements with Accountants on Accounting and Financial Disclosure.

Former independent accountants.

On April 30, 2014, we notified KBL, LLP (KBL), our independent registered public accounting firm, that it was being replaced.

The report of KBL on our financial statements as of and for the year ended December 31, 2012 and December 31, 2011 did not contain an adverse opinion or a disclaimer of opinion nor was it qualified or modified as to uncertainty, audit scope or accounting principles, except that the report included an explanatory paragraph relating to an uncertainty as to our ability to continue as a going concern.

The decision to discontinue the audit services of KBL was approved by our Board of Directors.

During the fiscal years ended December 31, 2012 and 2011 and through April 30, 2014, there has been no disagreement with KBL on any matter of accounting principles or practices, financial statement disclosure, or auditing scope or procedure, which disagreement, if not resolved to the satisfaction of KBL, would have caused KBL to make reference to the subject matter of the disagreement in its report.

There have been no reportable events as provided in Item 304 (a)(1)(v) of Regulation S-K up to and including the dismissal of KBL except for the material weakness in its system of internal controls over financial reporting which KBL advised us existed.

The controls designed were adequate for financial disclosures required for the preparation of our Form 10-Q and 10-K filings;

however due to lack of resources in our accounting department the controls were not operating effectively.

Our board of directors discussed this issue with KBL.

KBL has been fully authorized by us to answer all inquiries of KBL concerning the controls that were not operating effectively.

There are no limitations placed on KBL or KBL concerning the inquiry of any matter related to our financial reporting.

We provided KBL with a copy of the disclosure and requested that KBL furnish us with a letter addressed to the SEC stating whether it agreed with the above statements.

A copy of the letter from KBL, dated April 30, 2014 was filed as Exhibit 16.1 to the Form 8-K filed with the SEC on May 5, 2014.

New independent accountants.

On April 30, 2014, we retained Anton & Chia, LLP (A&C) as our new independent registered public accounting firm to audit Registrant’s financial statements for the fiscal year ending December 31, 2013.

The appointment was approved by our Board of Directors.

During our two most recent fiscal years and any subsequent interim period preceding such engagement, we have not previously consulted with A&C on the application of accounting principles to a specified transaction, or on the type of audit opinion that might be rendered on our financial statements, or any other matter that was the subject of a disagreement between us and A&C or was a reportable event.

In addition, we did not consult with A&C regarding the material weakness of our internal control over financial reporting prior to engaging A&C.

Compared sentence by sentence after normalising whitespace, quotation marks, case and digits, so re-formatting and restated figures do not read as changed language. Wording changes appear as one removal and one addition. The current filing and the prior one are authoritative.

What changed 10-K

Item 8. Financial Statements and Supplementary Data